➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: August 14, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Methoxsalen patents expire, and what generic alternatives are available?

Methoxsalen is a drug marketed by Actavis Inc, Ani Pharms Inc, and Strides Pharma. and is included in three NDAs.

The generic ingredient in METHOXSALEN is methoxsalen. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.

US ANDA Litigation and Generic Entry Outlook for Methoxsalen

A generic version of METHOXSALEN was approved as methoxsalen by STRIDES PHARMA on June 5th, 2014.

  Start Trial

Drug patent expirations by year for METHOXSALEN
Drug Prices for METHOXSALEN

See drug prices for METHOXSALEN

Recent Clinical Trials for METHOXSALEN

Identify potential brand extensions & 505(b)(2) entrants

Sarcoma Oncology Research Center, LLCPhase 2
Joseph Ahmed FoundationPhase 2
Tyme, IncPhase 2

See all METHOXSALEN clinical trials

Pharmacology for METHOXSALEN
Medical Subject Heading (MeSH) Categories for METHOXSALEN

US Patents and Regulatory Information for METHOXSALEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Inc METHOXSALEN methoxsalen CAPSULE;ORAL 202603-001 Jun 9, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc METHOXSALEN methoxsalen CAPSULE;ORAL 087781-001 Jun 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Strides Pharma METHOXSALEN methoxsalen CAPSULE;ORAL 202687-001 Jun 5, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.